Articles related to ASTHMA
Container Defect Prompts Recall of Albuterol Inhalers
Cipla’s recall of six batches of Albuterol Sulfate Inhalation Aerosol due to a container defect necessitates immediate attention for patient safety. Replacement inhalers must be obtained by consumers from these specific batches to prevent any potential adverse effects.
Allergy & Immunology July 31st 2023
FDA Panel Backs Novel Combination Inhaler for Asthma in Adults Only
Although the panel voted 16:1 for the new budesonide + albuterol inhaler in adults, they said the data does not support use in children and they were split on use in adolescents over the age of 12.
Allergy & Immunology November 29th 2022
MKSAP Quiz: Preparticipation Physical Examination for Sports
An 18-year-old man comes to you for a sports physical. He is asymptomatic, with no limitation in his exercise capacity. He has a history of exercise-induced bronchospasm for which he takes a budesonide-formoterol inhaler. He does not smoke, drink alcohol, or use any drugs. There is no family history of cardiac disease or sudden death. What’s the next appropriate test?
Cardiology September 26th 2022
Maternal Diet During Pregnancy May Impact Development of Asthma, Allergies in Offspring
At the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, Carina Venter, PhD, associate professor of pediatrics at Children’s Hospital Colorado and the University of Colorado Denver School of Medicine, provided the latest data on the role that maternal diet during pregnancy may have on the infant microbiome and the subsequent development of allergies and asthma. The findings are that eating plenty of vegetables and limited fried, low-fiber, and sugary foods may prevent asthma and allergies in unborn children.
Allergy & Immunology March 8th 2022
Outpatient Management of Asthma in Adults
The Global Strategy for Asthma Management and Prevention (GINA) has published its annual report on asthma management and prevention. Key recommendations include that adults with asthma should receive combination therapy with an inhaled corticosteroid and a long-acting beta-agonist on an as-needed basis. The recommended option is low-dose budesonide-formoterol, or beclomethasone-formoterol as an alternative treatment. Short-acting inhaled beta agonists as rescue medication is discouraged.
Allergy & Immunology November 9th 2021